Literature DB >> 2958185

The effect of experimental iron-overload on splenic T cell function: analysis using cloning techniques.

M F Good1, D E Chapman, L W Powell, J W Halliday.   

Abstract

The effect of iron-overload on cell-mediated immunity was examined in C57 mice. Two methods of iron-loading were used: (i) dietary carbonyl iron which produced iron-loading primarily of parenchymal cells or (ii) intraperitoneal administration of iron-dextran which produced iron-loading predominantly of Kupffer cells. Both methods of iron-loading resulted in a diminished capacity of spleen cells to generate an allo-specific cytotoxic response in the absence of exogenous interleukin 2 (IL-2). Exogenous IL-2, however, restored the ability of spleen cells from iron-loaded mice to generate allo-specific cytotoxicity in bulk culture. Clonal assays for the precursor cells of cytotoxic T lymphocytes (CTL-P), performed in the presence of added IL-2, demonstrated that iron-loaded mice contained normal numbers of CTL-P. However, cultures of spleen cells from carbonyl iron-loaded mice generated less IL-2 following Concanavalin A stimulation, apparently as a result of a reduction in the number of IL-2-secreting cells amongst the spleen cell population. This work presents further evidence that iron-overload is associated with defective immunoregulatory control.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958185      PMCID: PMC1542722     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Induction of sarcoma in the rat by iron-dextran complex.

Authors:  H G RICHMOND
Journal:  Br Med J       Date:  1959-04-11

2.  Suppressive effect of ferritin on in vitro lymphocyte function.

Authors:  Y Matzner; C Hershko; A Polliack; A M Konijn; G Izak
Journal:  Br J Haematol       Date:  1979-07       Impact factor: 6.998

3.  Generalized Yersinia enterocolitica infection.

Authors:  A R Rabson; A F Hallett; H J Koornhof
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

4.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

5.  A non-transferrin-bound serum iron in idiopathic hemochromatosis.

Authors:  R G Batey; P Lai Chung Fong; S Shamir; S Sherlock
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

6.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

Authors:  C Niederau; R Fischer; A Sonnenberg; W Stremmel; H J Trampisch; G Strohmeyer
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

7.  Influence of iron on in vivo proliferation and lethality of L1210 cells.

Authors:  R J Bergeron; R R Streiff; G T Elliott
Journal:  J Nutr       Date:  1985-03       Impact factor: 4.798

Review 8.  Iron, infection, and neoplasia.

Authors:  E D Weinberg
Journal:  Clin Physiol Biochem       Date:  1986

9.  Characteristics of tolerance induction among adult hapten-specific T lymphocyte precursors revealed by clonal analysis.

Authors:  M F Good; G J Nossal
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

10.  Intramuscular injections of iron compounds and oncogenesis in man.

Authors:  K Weinbren; R Salm; G Greenberg
Journal:  Br Med J       Date:  1978-03-18
View more
  3 in total

Review 1.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  The effect of non-transferrin-bound iron on murine T lymphocyte subsets: analysis by clonal techniques.

Authors:  M F Good; L W Powell; J W Halliday
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

3.  Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis.

Authors:  Kristin M Van Den Ham; Marina Tiemi Shio; Anthony Rainone; Sylvie Fournier; Connie M Krawczyk; Martin Olivier
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.